跳至主要内容
临床试验/NCT05397392
NCT05397392招募中不适用

Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome

Nanjing First Hospital, Nanjing Medical University0 个研究点目标入组 1,200 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,200
主要终点
Hospitalization due to worsening of renal or cardiac function

研究概览

简要总结

To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes

详细描述

Cardiorenal syndrome is a clinical syndrome caused by acute or chronic injury of one of the heart and kidney resulting to acute or chronic dysfunction of the other organ. In recent years, the morbidity of cardiorenal syndrome has increased rapidly in China. Its condition is complex and difficult to treat. Due to the lack of studies specifically targeting the cardiorenal syndrome population, there is no systematic in-depth understanding of the pathogenesis and risk factors of this kind of disease. In clinic, the course of various types of cardiorenal syndrome is complex and difficult to be summarized into a specific type. Therefore, we intend to conduct a clinical systematic observation and research on such patients so as to optimize a more reasonable treatment scheme.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients meet the diagnosis of various types of cardiorenal syndrome according to the classification standards of various types formulated by KDIGO and ADQI expert consensus. Different syndromes were identified and classified into five subtypes. Acute CRS (type 1): acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. Chronic cardio-renal syndrome (type 2): chronic abnormalities in heart function (CHF-CHD) leading to kidney injury and/or dysfunction. Acute reno-cardiac syndrome (type 3): acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction. Chronic reno-cardiac syndrome (type 4): chronic kidney disease leading to heart injury, disease, and/or dysfunction. Secondary CRS (type 5): systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.

排除标准

  • Pregnant or breastfeeding women; Female patients with recent birth plans; Patients who cannot follow up on medications.

结局指标

主要结局

Hospitalization due to worsening of renal or cardiac function

时间窗: 1 year

eGFR continuously decreased by more than 25% within one year; NYHA cardiac function class III or above requires intravenous pharmacological agents; deterioration of cardiac or kidney function requiring dialysis

All-cause deaths

时间窗: 1 year

Deaths due to disease progression

次要结局

  • Acute kidney injury(1 year)
  • End-stage renal disease requires maintenance dialysis(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验